Tech Company Financing Transactions

Centauri Therapeutics Funding Round

On 2/28/2022, Centauri Therapeutics secured $32 million in Series A financing from Boehringer Ingelheim Venture Fund, Evotec and Novo Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Discovery Park
Kent, CT13 9ND
United Kingdom

Phone

+44 (0) 1304 728610

Website

www.centauritherapeutics.com

Email Address

[email protected]

Overview

Centauri Therapeutics Limited is a UK-based biotechnology company focused on the discovery and development of novel molecules targeting life threatening diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Scientific Officer

Michael Westby

        

Co-Founder

Stuart Lawson

        

Browse more venture capital transactions:

Prev: 2/28/2022: NourishedRx venture capital transaction
Next: 2/28/2022: Check Technologies venture capital transaction

Share this article

Where The Data Comes From

We do our best to document all VC transactions involving tech companies. VC transactions on this site are derived from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary